Archives

by in
Entry Author Date Location
Sold For Parts, Accelerator Grad Allozyne Reaches End of the Line 09/18/14 Seattle
Tokai Bags $97M For Prostate Cancer Drug in Upsized IPO 09/17/14 Boston
MyoKardia, Sanofi Ink $200M+ Deal for Targeted Heart Drugs 09/17/14 San Francisco
Proteon, Moving on From Ill-Fated Novartis Deal, Files IPO Pitch 09/16/14 Boston
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
Pappas, Chiesi Venture Fund Joins Ranks of Pharma & VC Partnerships 09/10/14 Raleigh Durham
An Intriguing Program Takes on Tropical Diseases—But Not Ebola 09/10/14 National
To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M 09/09/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
East Coast Biotech Roundup: Infinity, Merck, Voyager, Ebola, & More 09/05/14 Boston
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug 09/04/14 New York
Google’s Calico Nabs First Partner, Cuts $1.5B R&D Deal With AbbVie 09/03/14 San Francisco
Steven Paul, Former Lilly R&D Chief, Takes Head Seat at Voyager 09/03/14 Boston
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug 09/03/14 Boston
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed 09/02/14 San Francisco
ARCH Venture Exploits IPO Window To Raise $400M Fund, Its Eighth 08/27/14 Seattle
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return 08/26/14 National
Roche To Pay $8.3B For Intermune: Who’s Next In Pulmonary Fibrosis? 08/25/14 San Francisco
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
Join Us For “Boston’s Life Science Disruptors” on Oct. 8 08/21/14 Boston
NJ’s Medicine Chest Thins Again as GE Health Unit Heads for MA 08/19/14 Boston
Cellectar Biosciences Makes Nasdaq Debut With $12.5M Stock Offering 08/15/14 Wisconsin
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
For Exact Sciences, It’s Put Up or Shut Up Time For Colon Cancer Test 08/14/14 Wisconsin
Novartis Helps Pour $16M Into Seventh Sense for Pain-Free Blood Tests 08/13/14 Boston
Tokai, Chasing the Field in Prostate Cancer, Files For IPO 08/12/14 Boston
While Protesters Rage Against Tech Giants, Biotech Drives Quietly By 08/12/14 National
Standing on a Ledge Once Again, Amicus Holds Breath for Latest Study 08/11/14 New York
Page 2 of 87 « previous page · next page »